JP Morgan: NeoGenomics Expects NGS Business to Grow at Least 25 Percent in 2025
SAN FRANCISCO – In a presentation at the JP Morgan Healthcare Conference here on Wednesday, NeoGenomics CEO Chris Smith offered financial guidance for fiscal year 2025 and additional information about the company's long-term financial plans. Last week, …